CMS’s 2026 reimbursement overhaul for skin substitutes signals more than cost control. It marks a sharp rise in audits, enforcement, and compliance risk for wound care providers. Clinics relying on advanced wound care billing should prepare now, as regulators and payers intensify scrutiny across documentation, utilization, and financial relationships.
